4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-041628
President, R&D sold 8,000 shares at $20.00 ($160,000)
- President, R&D acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X03/doc4.xml…